热门资讯> 正文
CareDx任命新首席财务官
2025-08-07 06:53
- CareDx (NASDAQ:CDNA) has appointed Nathan Smith as its new chief financial officer.
- Smith brings over 14 years of experience in molecular diagnostics, including senior roles at Myriad Genetics, Blackrock Neurotech, and WIN Brands.
- Source: Press release
More on CareDx
- CareDx: The Transplant Diagnostics Leader, But Challenges Will Increase On The Road Ahead
- CareDx Q2 2025 Earnings Preview
- CareDx Non-GAAP EPS of $0.10 misses by $0.02
- Seeking Alpha’s Quant Rating on CareDx
- Historical earnings data for CareDx
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。